Frontiers

Nature Medicine | Bispecific Innate Immune Cell Engager Targeting CD30 Combined with Allogeneic NK Cells for Treating Refractory Lymphoma

Science Translational Medicine | Peripheral Blood Transcriptomic Analysis Predicts Breast Cancer Subtypes and Response to Neoadjuvant Chemotherapy and Immunotherapy

Nature Communications | Tim-3 Agonist Suppresses ILC2 Function and Attenuates Airway Hyperreactivity via the NLK Pathway

Gut | Engineered Virus-Hunter Vaccine Breaks Immune Tolerance in Chronic Hepatitis B

Nature Communications | High-risk EBV promotes immune evasion in nasopharyngeal carcinoma by upregulating HLA-DP via BALF2-HR

Nature Cancer | p95HER2 Limits T-DXd Efficacy through an Immunosuppressive Program

Antibodies | Efficacy and Safety of the CD20×CD3 Bispecific Antibody Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma

Antibodies | Immune-Related Adverse Events and Survival Outcomes in Cervical Cancer Patients Treated with Cemiplimab

Advanced Science | Targeting Schwannoma-Neuron-Macrophage Crosstalk Suppresses NF2-Independent Schwannoma Growth and Pain

Circulation | Mechanism Study on PRMT3-Mediated Arginine Methylation of PCSK9 in Regulating Aortic Valve Calcification